Vimarsana
Biggest News Aggregation in the World

James Gerson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from James Gerson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In James Gerson Today - Breaking & Trending Today

UVM Cancer Center to hold 26th Annual Women's Health and Cancer Conference on Sept. 29 | News - Vimarsana News

UVM Cancer Center to hold 26th Annual Women's Health and Cancer Conference on Sept. 29 | News

Patient advocate Kristin Flanary, aka "Lady Glaucomflecken," will deliver the keynote speech, titled "Wife and Death," at the UVM Cancer Center's 26th annual Women’s Health and Cancer Conference on Sept.

University of Vermont Cancer Center to offer a novel, highly effective form of cancer treatment - Vimarsana News

University of Vermont Cancer Center to offer a novel, highly effective form of cancer treatment

The University of Vermont Cancer Center will offer a novel, highly effective form of cancer treatment called CAR T-cell therapy beginning in February, when final accreditation and approval to begin treating patients is expected.

UVM Cancer Center announces availability of new CAR T-cell treatment for blood cancer patients - Vimarsana News

UVM Cancer Center announces availability of new CAR T-cell treatment for blood cancer patients

A cutting-edge treatment that uses the body’s own immune system to destroy cancer cells is now available at the University of Vermont Cancer Center.

Source: wamc.org
UVM Cancer Center rolls out custom-made immunotherapy - Vimarsana News

UVM Cancer Center rolls out custom-made immunotherapy

CAR T-cell therapy works by genetically modifying the patient’s white blood cells to make them more able to find and attack different kinds of blood cancer.

UVM Cancer Center expands treatment options; adds CAR T-cells therapy - Vimarsana News

UVM Cancer Center expands treatment options; adds CAR T-cells therapy

UVM Cancer Center will begin offering a type of treatment for blood cancers that uses a patient's own immune cells to attack cancer.